Milestones in the development of modern Parkinson therapy.
D015083:2,3-Diketogulonic Acid / Q000627:therapeutic use; D000496:Alloxan / Q000627:therapeutic use; D001519:Behavior / Q000187:drug effects; D001971:Bromocriptine / Q000627:therapeutic use; D004338:Drug Combinations / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005290:Ferric Compounds / Q000627:therapeutic use; D006801:Humans; D007980:Levodopa / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D009462:Neurology / Q000639:trends*; D010300:Parkinson Disease / Q000188:drug therapy*; D012642:Selegiline / Q000627:therapeutic use; D014364:Tryptophan / Q000627:therapeutic use
D004338:Drug Combinations; D005290:Ferric Compounds; D012642:Selegiline; D015083:2,3-Diketogulonic Acid; D001971:Bromocriptine; D007980:Levodopa; C008747:oxyferriscorbone; D000496:Alloxan; D014364:Tryptophan